Immune responses to COVID‐19 booster vaccinations in intensively anti‐CD38 antibody treated patients with ultra‐high‐risk multiple myeloma: results from the Myeloma UK (MUK) nine OPTIMUM trial
暂无分享,去创建一个
M. Drayson | S. Faustini | J. Heaney | M. Jenner | Z. Stamataki | G. Cook | G. Pratt | M. Kaiser | A. Richter | R. Owen | Harriet J. Hill | S. Brown | A. Hall | S. Roberts